Literature DB >> 15607397

Wall stress modulates brain natriuretic peptide production in pressure overload cardiomyopathy.

Marc Vanderheyden1, Marc Goethals, Sofie Verstreken, Bernard De Bruyne, Kristin Muller, Eddy Van Schuerbeeck, Jozef Bartunek.   

Abstract

OBJECTIVES: We postulated that both diastolic and systolic load modulate B-type natriuretic peptide (BNP) production in human pressure overload hypertrophy/failure.
BACKGROUND: In isolated myocytes, diastolic stretch induces BNP messenger ribonucleic acid expression. However, the mechanism of the BNP release in human hypertrophy remains controversial.
METHODS: In 40 patients with symptomatic aortic stenosis (AS), left ventricular (LV) performance and systolic and diastolic wall stress were calculated from combined invasive and echocardiographic data. Plasma BNP was determined by the rapid point-of-care bedside analyzer (Biosite Triage, Biosite Diagnostics Inc., San Diego, California).
RESULTS: A significant relationship was observed between plasma BNP and pulmonary capillary wedge pressure (p < 0.001), fractional shortening (p = 0.001), and aortic valve area (p = 0.006). Furthermore, a significant correlation was noted between BNP and LV mass index (p = 0.005) as well as between BNP and markers of diastolic load such as LV end-diastolic wall stress (p = 0.011), indexed LV end-diastolic volume (p < 0.001), and isovolumic relaxation time (p = 0.02). Preoperative BNP levels were elevated in patients with AS compared with patients without AS. Plasma BNP was higher in AS patients with impaired versus normal preload reserve (297 +/- 56 pg/ml vs. 168 +/- 44 pg/ml; p = 0.017) and in AS patients with clinical deterioration after valve replacement compared with those without (399 +/- 82 pg/ml vs. 124 +/- 41 pg/ml; p = 0.011).
CONCLUSIONS: In patients with AS, BNP appears to be regulated not only by systolic but also by diastolic load. This supports the hypothesis that myocardial stretch modulates BNP production in human pressure overload hypertrophy/failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15607397     DOI: 10.1016/j.jacc.2004.09.038

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  37 in total

1.  Impact of chronic atrial fibrillation in patients with severe heart failure and indication for CRT: data of two registries with 711 patients (1999-2006 and 2007-6/2008).

Authors:  G Luedorff; R Grove; M Kowalski; E Wolff; J Thale; W Kranig
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-12

Review 2.  Role of Sam68 as an adaptor protein in signal transduction.

Authors:  S Najib; C Martín-Romero; C González-Yanes; V Sánchez-Margalet
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

Review 3.  Natriuretic peptides in cardiovascular diseases: current use and perspectives.

Authors:  Massimo Volpe; Speranza Rubattu; John Burnett
Journal:  Eur Heart J       Date:  2013-11-13       Impact factor: 29.983

4.  Changes in Biomarker Profile and Left Ventricular Hypertrophy Regression: Results from the Frequent Hemodialysis Network Trials.

Authors:  Christopher T Chan; George A Kaysen; Gerald J Beck; Minwei Li; Joan Lo; Michael V Rocco; Alan S Kliger
Journal:  Am J Nephrol       Date:  2018-04-05       Impact factor: 3.754

5.  The relationship between long-term changes in plasma B-type natriuretic peptide levels and electrocardiographic findings.

Authors:  Shinji Fukazawa; Koji Teruya; Takamoto Uemura; Tomoko Omine; Tomoko Matsui; Nobuo Takeda; Hiroteru Okamoto; Kaoru Ichikawa; Kosuke Tsuchida; Rieko Takemae; Momoo Matsuda; Tooru Tsunoda
Journal:  Environ Health Prev Med       Date:  2008-04-04       Impact factor: 3.674

6.  Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention.

Authors:  Bin Peng; Hao Xia; Aihua Ni; Gang Wu; Xuejun Jiang
Journal:  Herz       Date:  2015-05-22       Impact factor: 1.443

7.  Amount of left ventricular hypertrophy determines the plasma N-terminal pro-brain natriuretic peptide level in patients with hypertrophic cardiomyopathy and normal left ventricular ejection fraction.

Authors:  Seon Woon Kim; Seung Woo Park; Seong-Hoon Lim; Sung Uk Kwon; Yu Jeong Choi; Man Ki Park; Sang-Chol Lee; Sang Hoon Lee; Jeong Euy Park; Eun-Seok Jeon
Journal:  Clin Cardiol       Date:  2006-04       Impact factor: 2.882

8.  The Relationships Between BNP and Neurocardiac Injury Severity, Noninvasive Cardiac Output, and Outcomes After Aneurysmal Subarachnoid Hemorrhage.

Authors:  Amber McAteer; Marilyn Hravnak; Yuefang Chang; Elizabeth A Crago; Matthew J Gallek; Khalil M Yousef
Journal:  Biol Res Nurs       Date:  2017-06-19       Impact factor: 2.522

9.  N-terminal pro-B-type natriuretic peptide measurement is useful in predicting left ventricular hypertrophy regression after aortic valve replacement in patients with severe aortic stenosis.

Authors:  Mirae Lee; Jin-Oh Choi; Sung-Ji Park; Eun Young Kim; PyoWon Park; Jae K Oh; Eun-Seok Jeon
Journal:  Heart Asia       Date:  2015-04-27

Review 10.  Natriuretic peptides in the management of aortic stenosis.

Authors:  Jutta Bergler-Klein
Journal:  Curr Cardiol Rep       Date:  2009-03       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.